MDXG (mimedx.com) Rasio Nilai Pasar marang Nilai Buku

Simbol resmi perusahaan MiMedx Group Inc (MDXG)

MiMedx Group, Inc. (MDXG) dominates the regenerative therapy segment thanks to its exclusive PURION technology, which ensures steady demand for bio-implants. The market dynamics of the company's securities, where the indicator stands at 2.59, price in the dependence on the volume of surgeries and Medicare payments. However, legal disputes and regulatory uncertainty regarding the classification of human tissue products continue to hinder growth.

MDXG MiMedx Corp: Nilai Pasar marang Nilai Buku ing interval 04.07.2022 - 28.10.2026

Rincian metrik keuangan lan pasar MiMedx Group Inc (MDXG)

- rega lan prakiraan konsensus rega:
Rega saham MiMedx Group, Inc.|MDXG - Rentang target analis
- data kapitalisasi pasar:
Nilai pasar MiMedx Group|MDXG - Nilai Wutuh Bisnis
- data kapitalisasi buku:
Nilai Buku saben Saham MiMedx|MDXG - Nilai Akuntansi Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku mimedx.com|MDXG - Total Aset Perusahaan
- data utang lan likuiditas:
Utang marang Ekuitas MiMedx Group, Inc.|MDXG - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas MiMedx Group|MDXG - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku MiMedx Group
Analisis wiwitan perusahaan:MiMedx Group, Inc. - MDXG
Produk asli MiMedx Group

This indicator measures the market value premium over net assets, demonstrating the extent to which investors are willing to pay a premium for equity relative to its book value. Analyzing the market-to-book ratio allows for an assessment of the scaling potential of MiMedx Group, Inc. (MDXG), where the high margins of replicating regenerative technologies often justify a significant divergence of share prices from book value.

Pesaing utama

Rasio Kapitalisasi Pasar marang Nilai Buku ASND (Ascendis Pharma A/S)|MDGL (madrigalpharma.com) - Rasio Nilai Pasar marang Ekuitas|Rasio Nilai Pasar marang Nilai Buku Corcept Therapeutics Incorporated CORT|Kapitalisasi Pasar marang Aset Bersih Rhythm Pharma|Akero Therapeutics Inc (AKRO) - Rasio Kapitalisasi Pasar marang Nilai Buku|Nilai Pasar marang Nilai Buku Metsera Therapeutics (MTSR)|Rasio Kapitalisasi Pasar marang Nilai Buku MLTX (MoonLake Immunotherapeutics)|crinetics.com - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku NewAmsterdam Pharma Company N.V. (NAMS)|SLNO: Nilai Pasar marang Nilai Buku|FOLD (Amicus Pharma) - Rasio Nilai Pasar marang Nilai Buku|89bio Pharma (ETNB) - Rasio Kapitalisasi marang Aset Bersih|AGIO (Agios Pharmaceuticals) - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku structuretx.com (GPCR)|Rezolute (RZLT) - Rasio Kapitalisasi marang Aset Bersih|Nilai Pasar marang Nilai Buku LXRX (Lexicon Pharmaceuticals Inc)|MBX Bio - Rasio Nilai Pasar marang Nilai Buku|Rasio Kapitalisasi marang Aset Bersih Altimmune Pharma ALT|AARD (Aardvark Therapeutics Inc) - Rasio Kapitalisasi Pasar marang Nilai Buku|sagimet.com (SGMT) - Koefisien Nilai Pasar marang Nilai Buku|BIOA - Rasio Kapitalisasi marang Aset Bersih|Biomea Fusion Inc (BMEA) - Multiplikator Kapitalisasi Pasar marang Nilai Buku|QNCX (Quince Therapeutics Inc) - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku Fractyl Health, Inc|Rasio Kapitalisasi Pasar marang Nilai Buku vTv Therapeutics Inc. (VTVT)|Rasio Nilai Pasar marang Nilai Buku ATPC (agapeatpgroup.com)|PLUR: Rasio Nilai Pasar marang Nilai Buku|Synlogic Inc. - Koefisien Nilai Pasar marang Nilai Buku|LPCN - Rasio Nilai Pasar marang Nilai Buku|MTNB - Rasio Nilai Pasar marang Nilai Buku|Spruce Biosciences - Rasio Kapitalisasi Pasar marang Nilai Buku|GLTO (galecto.com) - Kapitalisasi Pasar marang Nilai Buku|CTCX: Rasio Nilai Pasar marang Nilai Buku|Kapitalisasi Pasar marang Nilai Buku LUMO|Rasio Nilai Pasar marang Nilai Buku ONVO (Organovo Holdings Inc)|Rasio Kapitalisasi marang Aset Bersih RDUS (Radius Pharmaceuticals)